Company Filing History:
1 out of 1,168 
1 out of 3,539 
Years Active: 2014-2022
Title: Yardena R Samuels: Innovator in Cancer Treatment
Introduction
Yardena R Samuels is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. With a total of 2 patents, his work focuses on advancing therapeutic methods for melanoma and other cancers.
Latest Patents
Samuels' latest patents include groundbreaking developments in cancer therapy. One patent details a combination therapy for the treatment of cancer, which encompasses various uses and applications. Another significant patent involves GRM3 mutations and their use for the diagnosis and treatment of melanoma. This patent describes a G-protein coupled receptor (GPCR)-directed mutational analysis of tumor DNA obtained from melanoma tissue samples. The research identifies the GRM3 gene as the most highly mutated GPCR gene in this context. Functional characterization of GRM3 mutants has revealed their role in promoting MEK activation, anchorage-independent cell growth, and metastasis. The methods provided in this patent offer new avenues for diagnosing and treating melanoma by detecting GRM3 mutations and administering appropriate therapies.
Career Highlights
Throughout his career, Yardena R Samuels has worked with esteemed organizations such as Yeda Research and Development Co. Ltd. and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to contribute to significant advancements in medical research and innovation.
Collaborations
Samuels has collaborated with notable colleagues, including Rand Arafeh and Karen Flores. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in cancer research.
Conclusion
Yardena R Samuels stands out as an influential inventor in the realm of cancer treatment. His innovative patents and collaborative efforts continue to pave the way for advancements in medical science.